Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 35 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Plain-language summary

Abstract Introduction In 2017, Medicare introducee Cognitive Assessment and Care Plan (CACP) billing code, which reimburses healthcare providers for comprehensive dementia visits. Uptake of CACP has been very low; drivers of use and underuse are not known. We sought to understand whether CACP spreads through practices after a champion provider adopts CACP. Methods We used 100% samples of Medicare Fee‐For‐Service claims and Medicare Advantage encounters from 2017 to 2022 to model the relationship between peer CACP adoption and individual CACP adoption. Results Our sample contained 607,164 providers, 8553 of whom billed for CACP from 2017 to 2022. Having a peer adopt CACP was associated with higher odds of adopting CACP individually (odds ratio [OR]: 17.1, confidence interval 95% CI: 16.1 to 18.2). The association was stronger if the peer shared the same specialty (OR: 23.5, 95% CI: 22.1 to 24.9). Conclusion Being exposed to a peer who adopted CACP was a strong predictor of providers’ own uptake of CACP.

What this study adds

Evidence grade: Low

This study looked at whether doctors are more likely to start billing for dementia care planning visits when a colleague does so. Reported effect size: OR: 23.5.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Mulcahy, J., Amjad, H., Neprash, H. T., Huckfeldt, P. J., & Gaugler, J. E. (2026). Healthcare provider adoption of cognitive assessment and care planning services associated with uptake among peers. Alzheimer s & Dementia Behavior & Socioeconomics of Aging. https://doi.org/10.1002/bsa3.70075

Vancouver

Mulcahy J, Amjad H, Neprash HT, Huckfeldt PJ, Gaugler JE. Healthcare provider adoption of cognitive assessment and care planning services associated with uptake among peers. Alzheimer s & Dementia Behavior & Socioeconomics of Aging. 2026. doi:10.1002/bsa3.70075.

BibTeX

@article{mulcahy2026-b8da6e83,
  author  = {Mulcahy, John and Amjad, Halima and Neprash, Hannah T. and Huckfeldt, Peter J. and Gaugler, Joseph E.},
  title   = {{Healthcare provider adoption of cognitive assessment and care planning services associated with uptake among peers}},
  journal = {Alzheimer s \& Dementia Behavior \& Socioeconomics of Aging},
  year    = {2026},
  doi     = {10.1002/bsa3.70075},
  url     = {https://doi.org/10.1002/bsa3.70075}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This study looked at whether doctors are more likely to start billing for dementia care planning visits when a colleague does so. It found that having a peer adopt the billing code was strongly linked to a provider adopting it too, but it does not test any treatment, cure, or prevention of Alzheimer's disease.

Study details

How this study scored 35/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 0 of 4; Effect reported 3 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 2 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. Total 35 of 100.35 of 100 points earned65 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Behavior & Socioeconomics of Aging)
Journal's citation record 0 / 4 Alzheimer s & Dementia Behavior & Socioeconomics of Aging: journal h-index 4 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Joseph E. Gaugler: h-index 55 (OpenAlex, whole career)
Institution's track record 2 / 3 Johns Hopkins University: institution h-index 2,306 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Total 35 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Health systems and care delivery from nearby years

Also tagged “nursing”

995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →